Spotlight
Clinical Role
Clinical
Supplement Spotlight
CME/CE
Subscribe
Hepatitis C: Short Term Drug Costs Versus Long Term Care Costs
Marc O'Connor, Chief Operating Officer of Curant Health, discusses how to evaluate the short term cost of treatment with new hepatitis C drugs versus the long term cost of care.
Marc O'Connor, Chief Operating Officer of Curant Health, discusses how to evaluate the short term cost of treatment with new hepatitis C drugs versus the long term cost of care.
This video was recorded courtesy of Armada Health Care at the 2015 Armada Specialty Pharmacy Summit in Las Vegas, Nevada.
Recent Videos
Related Content
